TrialSignal transduction and targeted therapy2025

Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trial.

Qin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.